Keith, Progen are I believe targeting Melanoma for the "Orphan...

Keith,
Progen are I believe targeting Melanoma for the "Orphan Drug" status. Solbec on the other hand are targeting Mesothelioma and Asbestos related lung cancers. this PGL approval should not make any difference to Solbecs application.


"Despite these rising figures, the incidence of Mesotholemia is still sufficiently low for SBP002 to be potentially classified as an Orphan Drug – i.e. one relevant to an illness affecting a relatively small proportion of the population, which can be fast-tracked through clinical trials."

Tom.